US EditionHere’s where the AstraZeneca share price could end the year
Summary by The Motley Fool UK
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Here’s where the AstraZeneca share price could end the year
The AstraZeneca (LSE:AZN) share price is down 10% in a year. That’s clearly a disappointment for investors, and it marks a deviation from the positive trajectory of the past decade. In that period, the stock’s moved from a little over £40 a share to nearly £110 today, so it’s been one of the UK’s most appealing growth stories. But the company’s relative underperformance against UK stocks over 12 months can be traced to several things. One of the…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
